Palantir Hits 2-Year High: Can Improved Outlook, Buybacks Sustain Uptrend?

 | Nov 29, 2023 07:53

  • Palantir recently hit two-year highs at $21.85, fueled by positive factors like government revenue, and a $1 billion buyback program
  • Despite a partial pullback tied to lower-than-expected deals with the UK National Health Service, PLTR's Q3 earnings surpassed expectations, prompting a 26% share price increase
  • Analysts anticipate a favorable outlook for Palantir, with projections of increased revenue and earnings, expecting a 20% annual revenue growth for the next two years.
  • Missed out on Black Friday? Secure your up to 60% discount on InvestingPro subscriptions with our extended Cyber Monday sale.
  • Palantir (NYSE:PLTR) is a key player in the artificial intelligence space and has been garnering investor attention. In the latter half of this year, the Denver, Colorado-based company's stock gained significant momentum and eventually made new two-year highs at $21.85 last week.

    A partial pullback from this peak was attributed to the somewhat lower-than-expected scale of Palantir's anticipated deal with the UK National Health Service.

    However, persistent positive factors, including the company's ongoing collaborations, substantial revenue from government agencies despite disruptions, a continuous uptick in commercial sales, and the announcement of a $1 billion buyback program, maintain high expectations for PLTR.

    Moreover, the third-quarter earnings exceeded expectations, sparking a substantial surge in the share price. Palantir posted an earnings per share of 7 cents with a revenue of $558.2 million in Q3, surpassing EPS expectations by 25%.

    In the wake of these financial results, the initial response to PLTR shares was a remarkable 26% increase.